Literature DB >> 10998464

Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population.

D Corella1, C Sáiz, M Guillén, O Portolés, F Mulet, J I González, J M Ordovás.   

Abstract

Genetic variants at the cholesteryl ester transfer protein (CETP) locus have been associated with CETP activity and mass, as well as plasma high density lipoprotein cholesterol (HDL-C) and apolipoprotein A-I levels. We have examined allele frequencies and lipid associations for the common CETP TaqIB polymorphism in a sample of 514 healthy subjects (231 men, mean age 37.4 years, and 283 women, mean age 35.7 years) residing in Valencia (Spain). The frequency of the less common TaqIB2 allele (0.351; 95% CI: 0.322-0. 380) was significantly lower than those reported for Northern European populations. Consistent with previous studies, we found a significant association of the TaqIB polymorphism with HDL-C levels. Homozygotes for the B1 allele had lower HDL-C levels than subjects carrying the B2 allele (P trend<0.001 and 0.002, for men and women, respectively). No statistically significant genotype effects were observed for any of the other lipid measures. Multivariate models including TaqIB genotype, body mass index, smoking, alcohol, physical activity, marital status and education were fitted to predict HDL-C levels. The TaqIB polymorphism was consistently an independent predictor of HDL-C levels (P<0.001), and explained 5.8% of its variance. To evaluate gene-environmental interactions, first order interaction terms were tested into the multivariate model. No statistically significant interactions between the TaqIB genotypes and smoking, alcohol, physical activity or education were detected. In conclusion, we observed a significant association of the TaqIB polymorphism with HDL-C levels, which remained consistent across different levels of behavioral factors. Moreover, we found that the TaqIB2 allele frequency was lower in our sample than in other European populations, which could be a contributing factor to the unexpectedly high prevalence of coronary heart disease observed in the region of Valencia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10998464     DOI: 10.1016/s0021-9150(99)00477-3

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  20 in total

1.  Association between Opioid Receptor mu 1 (OPRM1) Gene Polymorphisms and Tobacco and Alcohol Consumption in a Spanish Population.

Authors:  Francesc Francès; Olga Portolés; Ana Castelló; Jose Antonio Costa; Fernando Verdú
Journal:  Bosn J Basic Med Sci       Date:  2015-04-25       Impact factor: 3.363

2.  Prevalence of the methylenetetrahydrofolate reductase 677C > T mutation in the Mediterranean Spanish population. Association with cardiovascular risk factors.

Authors:  M Guillén; D Corella; O Portolés; J I González; F Mulet; C Sáiz
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

3.  Gene-environment interactions of CETP gene variation in a high cardiovascular risk Mediterranean population.

Authors:  Dolores Corella; Paula Carrasco; Montserrat Fitó; Miguel Angel Martínez-González; Jordi Salas-Salvadó; Fernando Arós; José Lapetra; Marisa Guillén; Carolina Ortega-Azorín; Julia Warnberg; Miquel Fiol; Valentina Ruiz-Gutierrez; Lluís Serra-Majem; J Alfredo Martínez; Emilio Ros; Ramón Estruch
Journal:  J Lipid Res       Date:  2010-06-25       Impact factor: 5.922

4.  CETP genotype and changes in lipid levels in response to weight-loss diet intervention in the POUNDS LOST and DIRECT randomized trials.

Authors:  Qibin Qi; Ronen Durst; Dan Schwarzfuchs; Eran Leitersdorf; Shoshi Shpitzen; Yanping Li; Hongyu Wu; Catherine M Champagne; Frank B Hu; Meir J Stampfer; George A Bray; Frank M Sacks; Iris Shai; Lu Qi
Journal:  J Lipid Res       Date:  2014-12-29       Impact factor: 5.922

5.  Association of cholesteryl ester transfer protein (TaqIB) and apolipoprotein E (HhaI) gene variants with obesity.

Authors:  Neena Srivastava; B R Achyut; Jai Prakash; C G Agarwal; D C Pant; Balraj Mittal
Journal:  Mol Cell Biochem       Date:  2008-05-04       Impact factor: 3.396

Review 6.  Inhibition of cholesteryl ester transfer protein activity: a new therapeutic approach to raising high-density lipoprotein.

Authors:  Daniel J Rader
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

7.  The effect of a novel intergenic polymorphism (rs11774572) on HDL-cholesterol concentrations depends on TaqIB polymorphism in the cholesterol ester transfer protein gene.

Authors:  M Junyent; Y-C Lee; C E Smith; D K Arnett; M Y Tsai; E K Kabagambe; R J Straka; M Province; P An; C-Q Lai; L D Parnell; J Shen; I Borecki; J M Ordovas
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-04-11       Impact factor: 4.222

8.  The link between human and transgenic animal studies involving postprandial hypertriglyceridemia and CETP gene polymorphisms.

Authors:  Genovefa D Kolovou; Katherine K Anagnostopoulou; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2009-06-11

9.  Sex-associated effect of CETP and LPL polymorphisms on postprandial lipids in familial hypercholesterolaemia.

Authors:  Katherine K Anagnostopoulou; Genovefa D Kolovou; Peggy M Kostakou; Constantinos Mihas; Georgios Hatzigeorgiou; Christina Marvaki; Dimitrios Degiannis; Dimitri P Mikhailidis; Dennis V Cokkinos
Journal:  Lipids Health Dis       Date:  2009-06-26       Impact factor: 3.876

Review 10.  Lipoproteins, cholesterol homeostasis and cardiac health.

Authors:  Tyler F Daniels; Karen M Killinger; Jennifer J Michal; Raymond W Wright; Zhihua Jiang
Journal:  Int J Biol Sci       Date:  2009-06-29       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.